This week the European Commission announced that it had concluded exploratory talks with Valneva SE on an advance purchase agreement for 30 million doses of the French firm’s coronavirus vaccine, with the option to buy a further 30 million.
This is the eighth vaccine the commission is purchasing on behalf of the member states, having already signed contracts with...








